Table 2 WB analysis of SARS-CoV-2 anti-NP MAbs.
MAb | WB with recombinant NPs | WB with viral NPs | |||||||
|---|---|---|---|---|---|---|---|---|---|
NP-ΔN | NP | NPOmicron | SARS-CoV-NP | NL63-NP-ΔN | OC43-NP-ΔN | WT | XBB.1.5 | ||
anti- NP | 4G6 | + | + | + | + | − | − | + | + |
7F10 | – | + | + | + | − | − | + | + | |
anti- NP-ΔN | 1A6 | + | + | + | + | − | − | + | + |
4B3 | + | + | + | + | − | − | + | + | |
6G11 | + | + | + | + | − | − | + | + | |
12B2 | + | + | + | + | − | − | + | + | |
13C10 | + | + | + | + | − | − | + /− | + /− | |
16D9 | + | + /− | + /− | + | − | − | + | + | |
18A8 | + | + /− | + − | + | − | − | + | + | |